EN
VN

Vietnam proud - The FIRST & ONLY AI Product for X-ray Diagnostics in Vietnam and Southeast Asia that meets US FDA standards

Calendar 05/09/2022

At 5:00 AM on Vietnam National Day (Sep 2), VinBrain received the US Food and Drug Administration (FDA) clearance for DrAid™ Radiology V1. 

This is a radiological computer-assisted triage & notification software product designed to aid the clinical assessment of adult Chest X-Ray cases with features suggestive of pneumothorax.

Accordingly, DrAid™ Radiology V1 is the FIRST & ONLY AI product for X-ray Diagnostics in Vietnam and Southeast Asia that is cleared by FDA standards. This event has brought Vietnam into the Top 6 countries (USA, UK, Israel, Australia, Korea, and Vietnam) with an FDA-cleared AI product for chest X-ray cases with features suggestive of pneumothorax. 

The FDA is the United States Food and Drug Administration and is ultimately responsible for protecting and promoting public health through rigorous control and supervision. 

About DrAid™(*): 

DrAid™ is comprehensive artificial intelligence (AI) doctor assistant software developed by VinBrain to assist medical teams and doctors in diagnosing heart, lung and bone diseases based on digital medical images. The application is evaluated to have superior efficiency compared to traditional methods in observing and analyzing medical images, helping in reducing overload and limiting errors in diagnosis.

DrAid™ offers the following solutions to assist radiologists in care delivery:

DrAid Radiology V1: An AI-enabled triage and notification software designed to aid the clinical assessment of adult Chest X-ray cases with features suggestive of pneumothorax. The AI algorithm is FDA 510(K) cleared and apt for the US market. DrAid Radiology V1 offers radiologists outstanding advantages:

DrAid™ Appliance: an AI-enabled system to classify normal and abnormal with higher-than-average quality standards of primary care physicians. DrAid™ Appliance offers radiologists outstanding advantages:

 (*) Not all products and intended use claims are cleared for the US market. Please contact VinBrain directly for details. 

 

Share:

News Related

VINBRAIN HOSTED AN UNPRECEDENTED TALK OF TWO WORLD RENOWNED EXECUTIVE LEADERS IN MEDICAL TECHNOLOGY AND R&D     Calendar 30/03/2023

VINBRAIN HOSTED AN UNPRECEDENTED TALK OF TWO WORLD RENOWNED EXECUTIVE LEADERS IN MEDICAL TECHNOLOGY AND R&D

It was a busy week for VinBrain when we hosted unprecedented visit of two renowned...
View More
Dr. Gregory Moore: AI assistants to become ubiquitous across the global healthcare ecosystem Calendar 25/03/2023

Dr. Gregory Moore: AI assistants to become ubiquitous across the global healthcare ecosystem

Dr. Gregory Moore - a technology leader, engineer, radiologist, neuroradiologist, clinical informaticist, neuroscientist, and a...
View More
VINBRAIN TRỞ THÀNH THÀNH VIÊN CAO CẤP CỦA CHƯƠNG TRÌNH KHỞI NGHIỆP TOÀN CẦU NVIDIA INCEPTION Calendar 14/03/2023

VINBRAIN BECOMES NVIDIA INCEPTION PREMIER MEMBER

VinBrain has become a Premier member of NVIDIA Inception, a global program that provides cutting-edge...
View More
Calendar 15/02/2023

STANFORD UNIVERSITY AND VINBRAIN – TO DESIGN A STATE-OF-THE-ART AI-ENABLED PLATFORM TO ADVANCE MEDICAL DIAGNOSIS AND TREATMENTS

Stanford University and VinBrain signed a Data Use Agreement to improve the precision of Radiology...
View More
VINBRAIN VÀ MICROSOFT HOA KỲ HỢP TÁC PHÁT TRIỂN TRÍ TUỆ NHÂN TẠO TRONG Y TẾ Calendar 30/01/2023

A TURNING POINT IN VIETNAM’S HEALTHTECH: VINBRAIN ANNOUNCES COLLABORATION WITH MICROSOFT TO EXPAND AI-POWERED HEALTHCARE TO PATIENTS WORLDWIDE

VinBrain will collaborate with Microsoft in data sharing, product cross-validation, and product research & development.
View More

Top

Share